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Abstract
Objective: To assess the knowledge and practice of pediatricians about infants with phy-
siological reflux and gastroesophageal reflux disease.
Methods: 140 pediatricians were interviewed during two scientific events in 2009 and 
2010. The questions referred to two clinical cases of infants. One with symptoms of 
infant regurgitation (physiological reflux) and another with gastroesophageal reflux di-
sease.
Results: Among 140 pediatricians, 11.4% (n=16) and 62.1% (n=87) would require investi-
gation tests, respectively for infant regurgitation (physiological reflux) and gastroesopha-
geal reflux disease. A series of upper gastrointestinal exams would be the first requested 
with a higher frequency. Medication would be prescribed by 18.6% (n=6) in the case of 
physiological reflux and 87.1% (n=122) in the case of gastroesophageal reflux disease. 
Prokinetic drugs would be prescribed more frequently than gastric acid secretion inhi-
bitors. Sleeping position would be recommended by 94.2% (n=132) and 92.9% (n=130) of 
the respondents, respectively for the case of physiological reflux and gastroesophageal 
reflux disease; however, about half of the respondents would recommend the prone po-
sition. Only 10 (7.1%) of the pediatricians would exclude the cow’s milk protein from the 
infants’ diet. 
Conclusions: Approaches different from the international guidelines are often considered 
appropriate, especially when recommending a different position other than the supine 
and prescription of medication. In turn, the interviews enable us to infer the right ca-
pacity of the pediatricians to distinguish physiologic reflux and gastroesophageal reflux 
disease correctly.
© 2014 Sociedade de Pediatria de São Paulo. Published by Elsevier Editora Ltda. All rights 
reserved.
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Conhecimento e prática de pediatras brasileiros sobre a doença do refluxo gastroeso-
fágico em lactentes
Resumo
Objetivo: Avaliar o conhecimento e a prática de pediatras brasileiros na assistência ao 
lactente com refluxo fisiológico e doença do refluxo gastroesofágico.
Métodos: Foram entrevistados 140 médicos pediatras em dois eventos científicos realiza-
dos em 2009 e 2010. As perguntas referiam-se a dois casos clínicos de lactentes, um com 
quadro compatível com regurgitação do lactente (refluxo fisiológico) e outro com doença 
do refluxo gastroesofágico. 
Resultados: Dos 140 participantes, 11,4% (n=16) e 62,1% (n=87) solicitariam exame para 
lactentes, respectivamente, com refluxo fisiológico e doença do refluxo gastroesofágico. 
O primeiro exame solicitado com maior frequência seria a radiografia contratada de 
esôfago, estômago e duodeno. Medicação seria prescrita por 18,6% (n=26) para o caso 
de refluxo fisiológico e 87,1% (n=122) para o caso de doença do refluxo gastroesofágico. 
Procinéticos seriam prescritos com maior frequência do que os redutores da secreção 
ácida gástrica. Prescrição de posição para dormir fez parte das recomendações de 94,2% 
(n=132) e 92,9% (n=130) dos entrevistados, respectivamente, para os casos de refluxo 
fisiológico e doença do refluxo gastroesofágico, entretanto, cerca da metade dos entre-
vistados não recomendaria o decúbito dorsal. Prescrição de dieta de exclusão do leite de 
vaca para um lactente com quadro de doença do refluxo gastroesofágico seria prescrita 
por apenas 10 (7,1%) dos participantes. 
Conclusões: Condutas diferentes das diretrizes internacionais são frequentemente consi-
deradas adequadas, especialmente quanto à recomendação de posição diferente do de-
cúbito dorsal e prescrição de medicamentos. As respostas permitem inferir a capacidade 
de correta diferenciação entre refluxo fisiológico da doença de refluxo gastroesofágico.
© 2014 Sociedade de Pediatria de São Paulo. Publicado por Elsevier Editora Ltda. Todos os 
direitos reservados.
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Introduction
Vomiting and regurgitation frequently occur in infants, par-
ticularly in the first semester of life.1 Most cases are caused 
by physiological reflux.2,3 On the other hand, gastroesopha-
geal reflux disease (GERD) is characterized by varied and 
nonspecific clinical manifestations, not necessarily restrict-
ed to the digestive tract.3 The borderline between infant 
regurgitation and gastroesophageal reflux disease is not 
always easily defined and its differentiation is often a chal-
lenge when assisting the infant.2,3 In this context, there is 
a growing concern about excessive test requests and med-
ication prescriptions for healthy infants who have regurgi-
tation that is not caused by gastroesophageal reflux dis-
ease.2-5 On the other hand, GERD has varied symptoms, and 
if not properly managed, it can cause morbidity.2-4 
Guidelines for the care of infants with gastroesophageal 
reflux have been published in recent decades, with changes 
in the diagnostic and therapeutic recommendations.2,3,6,7 In 
2007, an article was published based on surveys carried out 
with professionals in North America, showing that despite 
the existence of several guidelines, many infants with phys-
iological gastroesophageal reflux are still being treated in 
North America as if they had GERD.8
Considering that surveys with professionals allow the 
guidance of continuing medical education programs, this 
study aimed to evaluate the knowledge and practice of 
Brazilian pediatricians when treating infants with physio-
logical reflux (infant regurgitation) and gastroesophageal 
reflux disease. 
Method
Data collection was carried out in two scientific events 
held in October 2009 and March 2010. A total of 140 physi-
cians were interviewed, 121 (86.4%) of which were females, 
after being randomly invited to participate. Regarding the 
year of graduation from Medical School, 56 had graduated 
after 2005, 34 had graduated between 2000 and 2005, and 
50 had graduated before 2000. All the participants signed 
the Free and Informed Consent Form after being informed 
about the purpose of the research. The project was 
approved by the Ethics Committee of Universidade Federal 
de São Paulo – Hospital São Paulo. 
Regarding the place where the physicians worked, 107 
(76%) respondents worked in the Southeast region, mostly 
in the state of São Paulo (66 in the capital city and 32 in 
the countryside). The other participants worked in the 
Northeast (n=8; 6%), South (n=9; 6.5%), North (n=7; 5.5%) 
and Central-West (n=8; 6%) regions.
The questions were formulated based on clinical scenar-
ios similar to those previously used in the literature:8
• Clinical scenario 1 (expectation that a diagnosis of regur-
gitation in infants or “physiological reflux” was estab-
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lished): “involuntary vomiting 2-4 times a day in a 2 
month-old infant receiving infant formula, at the 90th 
percentile for weight and height. No other clinical man-
ifestations.”
• Clinical scenario 2 (expectation that a diagnosis of gas-
troesophageal reflux disease was established): “five-
month-old infant receiving infant formula. The infant has 
frequent regurgitation since birth and for 2 months has 
been showing signs of irritability and difficulty gaining 
weight. She showed partial improvement with postural 
measures.” 
The following questions were formulated for each of the 
two clinical scenarios, and respondents were asked to 
answer them according to their medical practice: 1- Would 
you request any diagnostic tests? If the answer is yes, what 
is the first test?; 2 – Would you prescribe any medication? If 
yes, what would be your first prescription?; 3 – Would you 
modify the diet? If yes, what is your first recommendation?, 
and 4 – What sleeping position in the crib would you recom-
mend? Alternatives were offered for all questions as shown 
in Tables 1 and 2 of the Results section. The interview files 
included brand names of dietetic products and medications.
Considering the guideline of NASPGHAN/ESPGHAN3 (North 
American Society for Pediatric Gastroenterology, Hepatology 
and Nutrition/European Society for Pediatric 
Gastroenterology, Hepatology and Nutrition), published in 
2009, which emphasizes the association between cow’s 
milk allergy and gastroesophageal reflux in children, the 
following questions were formulated: “In infants, can gas-
troesophageal reflux disease be secondary to cow’s milk 
protein allergy?” If the answer is yes: 1 – Do you request 
any diagnostic test? If yes, what is the first test to be 
requested?; 2 – For an infant younger than 6 months of age, 
receiving infant formula with suspected gastroesophageal 
reflux disease secondary to cow’s milk protein allergy, 
which of the following dietary options do you initially pre-
scribe? 
Statistical analysis was carried out using Epi-Info soft-
ware, release 3.2.2 (Atlanta, GA, USA) to calculate the chi-
square test.
Results
Table 1 shows the results for the questions related to clin-
ical scenarios 1 and 2 regarding diagnostic tests required 
and medication prescription. For an infant with symptoms 
compatible with “physiological reflux”, 88.6% of respon-
dents would request no tests, and 18.6% would prescribe 
one prokinetic medication. For an infant with symptoms 
suggestive of GERD (clinical scenario 2), the proportions of 
respondents who would request tests and prescribe medi-
cations are higher. The initially requested test, in most 
cases, is the contrast radiography of the esophagus, stom-
ach and duodenum. In the presence of a scenario compati-
Table 1 Practice of pediatricians for a clinical scenario compatible with regurgitation in infants (physiological reflux) and 
another clinical scenario compatible with gastroesophageal reflux disease in the first semester of life regarding the indication 
for diagnostic tests and medication prescription.
Clinical Scenario 1:  
‘physiological reflux’ (n=140)
Clinical Scenario 2: 
GERD (n=140)
Do you request diagnostic tests? What is the 1st test?
No 124 (88.6%) 53 (37.9%)
Yes, what is the 1st test? 16 (11.4%) 87 (62.1%)
Contrast x-ray of esophagus, stomach and duodenum 7 (43.8%) 48 (55.1%)
24-hour esophageal pH-metry 5 (31.3%) 30 (34.5%)
Radionuclide study (scintigraphy) 1 (6.2%) 4 (4.6%)
Ultrasound for GER assessment 2 (12.5%) 2 (2.3%)
Upper digestive endoscopy with biopsy — 2 (2.3%)
Esophageal manometry —  (1.2%)
Plain abdominal x-ray 1 (6.2%) —
Do you prescribe any medication?
No 114 (81.4%) 18 (12.9%)
Yes, what is the first prescription? 26 (18.6%) 122 (87.1%)
Metoclopramide 1 (3.8%) —
Bromopride 13 (50.0%) 28 (23.0%)
Domperidone 12 (46.2%) 43 (35.2%)
Bromopride + ranitidine or omeprazole — 2 (1.6%)
Domperidone + ranitidine — 24 (19.7%)
Domperidone + omeprazole — 5 (4.1%)
Ranitidine — 15 (12.3%)
Omeprazole — 4 (3.3%)
Lansoprazole — 1 (0.8%)
GERD, gastroesophageal reflux disease; GER, gastroesophageal reflux.
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ble with GERD, 87.1% of respondents prescribe drugs, with 
a predominance of prokinetics and ranitidine.
Regarding the recommended position for the child in the 
crib (Table 2), we observe that approximately 95% of 
respondents advocate change for both clinical scenarios. 
However, positions that are different than the currently 
recommended (supine) would be suggested by a significant 
number of respondents (54.4% for infants with “physiologi-
cal reflux” and 42.1% for infants with symptoms compatible 
with GERD).
Industrialized thickened formula or adding thickener to 
formula is the predominant recommendation, emphasizing 
that the change in the type of bottle is recommended 
more frequently in the clinical scenario corresponding to 
GERD (Table 2). On the other hand, it should be noted that 
only ten respondents would exclude cow’s milk protein 
from the diet as the first dietary change for the infant with 
symptoms compatible with gastroesophageal reflux dis-
ease (Table 2).
Regarding the question about the possibility of gastro-
esophageal reflux disease being secondary to cow’s milk 
allergy, 105 (75.0%) of respondents answered yes, 16 (11.4%) 
answered no, and 19 (13.6%) said they are similar clinical 
manifestations, but are caused by different diseases. 
Of the 140 respondents, 86 (82.0%) would request some 
type of test, with the following being the initially request-
ed ones: measurement of specific IgE against cow’s milk 
would be requested by 44 (51.2%), serum total IgE by 24 
(27.9%), upper endoscopy with biopsy by 13 (15.1%), skin 
testing to evaluate sensitization by 4 (4.6%), and rectal 
biopsy by one respondent (1.2%). Although they were 
included in the alternatives, none of the respondents would 
request the following tests: contrast radiography of the 
esophagus, stomach and duodenum, occult blood in the 
stool, or measurement of α-1-antitrypsin in the stool. When 
the 140 respondents were asked about the first-choice for-
mula they would prescribe for infants with suspected gas-
troesophageal reflux secondary to cow’s milk allergy, the 
following answers were obtained: 70 (50.0%) would recom-
mend formula with extensively hydrolyzed protein, 44 
(31.4%) formula with soy protein isolate, 16 (11.4%) formu-
la with partially hydrolyzed protein, 7 (5.0%) amino acid-
based formula and 3 (2.1%) soy-based formula.
Table 3 shows the answers corresponding to clinical sce-
narios 1 and 2 according to the time of graduation from 
Medical School. There was a decrease in test requests as 
the years since graduation increased; however, no statisti-
cal significance was observed. For the other questions, the 
percentages were very similar, regardless of the year of 
graduation.
Discussion
Based on the expected answers related to test requests and 
medication prescription, the results allow us to infer that 
Table 2 Practice of pediatricians compatible with a clinical scenario of regurgitation in infants (“physiological reflux”) and 
another clinical scenario compatible with gastroesophageal reflux disease in the first semester of life regarding the 
recommendation for position in the crib and change in formula.
Scenario 1:  
“Physiological reflux” (n=140)
Scenario 2:  
GERD (n=140)
Would you recommend change in position? 
No 8 (5.8%) 10 (7.1%)
Yes, what is the position? 132 (94.2%) 130 (92.9%)
Prone position 1 (0.7%) 3 (2.4%)
Prone position with 30° elevation 29 (22.0%) 32 (24.6%)
Supine position 4 (3.0%) 5 (3.8%)
Supine position with 30° elevation 61 (46.2%) 54 (41.5%)
Right lateral decubitus 5 (3.8%) 3 (2.4%)
Right lateral decubitus with 30° elevation 7 (5.3%) 7 (5.4%)
Left lateral decubitus 8 (6.1%) 8 (6.1%)
Left lateral decubitus with 30° elevation 17 (12.9%) 18 (13.8%)
Any position — —
Would you recommend a change in formula?
No 98 (70.0%) 35 (25.0%)
Yes, what change? 42 (30.0%) 105 (75.0%)
Add a thickening agent to the bottle 8 (19.0%) 25 (23.8%)
Anti-regurgitation infant formula 33 (78.6%) 70 (66.7%)
Formula with partially hydrolyzed protein — 4 (0.3%)
Formula with extensively hydrolyzed proteins — —
Formula with amino acids — —
Formula with soy protein 2 (0.4%) 6 (0.6%)
GERD, gastroesophageal reflux disease.
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most pediatricians adequately differentiate regurgitation 
in infants (“physiological reflux”) from GERD (Table 1).
Regarding the required tests, there was a predominance 
of contrast x-ray of the esophagus, stomach and duode-
num, which is traditionally regarded as the first test to be 
requested to rule out digestive tract anatomical abnor-
malities.3,7 Esophageal pH-metry also appears as a fre-
quent request. In this case, it is likely to reflect knowl-
edge more than practice itself, considering that in the 
past, this test was indicated in literature as the gold stan-
dard for the diagnosis of GERD. In this context, it should 
be remembered that, in daily clinical practice, esopha-
geal pH monitoring is not always available and it is often 
not accepted by the family. Currently, for research pur-
poses, esophageal pH-metry has been replaced by the 
impedance–pH monitoring test, which still has a number 
of problems to be solved before it can be routinely applied 
in clinical practice.9 In turn, ultrasonography was indicat-
ed in a few answers (Table 1). Indeed, ultrasonography is 
not considered useful in evaluating the infant with gastro-
esophageal reflux, although it allows the visualization of 
the stomach reflux into the esophagus, which can occur 
both in physiological reflux and GERD.3,5 On the other 
hand, ultrasonography is a good method for the diagnosis 
of hypertrophic pyloric stenosis.3,5 It should be noted that, 
according to the Rome III criteria,2 the diagnosis of regur-
gitation in infants should be established mainly based on 
clinical manifestations. It is characterized by the occur-
rence of two or more regurgitations a day for three or 
more weeks in the absence of nausea, hematemesis, aspi-
ration, growth deficit and feeding and swallowing difficul-
ties or abnormal posture.2
Another remarkable result is the intention to prescribe 
prokinetics, especially domperidone and bromopride, 
which would be present in the prescription of 18.6% of 
pediatricians when treating a case of regurgitation in 
infants and in 72.8% of prescriptions in a patient with a 
clinical picture compatible with GERD (Table 1). In the case 
of GERD, prokinetics would often be associated by respon-
dents with medications for the reduction of gastric acid 
production. In the guideline of NASPGHAN/ESPGHAN,3 pub-
lished in 2009, prokinetic agents are not recommended due 
to the lack of clinical evidence of their efficacy for the 
treatment of gastroesophageal reflux in infants. The guide-
line3 emphasizes there is no “robust” evidence for the indi-
cation of domperidone based on a systematic review pub-
lished in England, which analyzed four studies published in 
the 1970s and 1980s.10 On the other hand, a meta-analysis 
carried out and published in Brazil, considering a broad 
definition for the outcome (change in reflux symptoms), 
concluded that domperidone has satisfactory clinical effi-
cacy.11 It is noteworthy that both meta-analyses10,11 were 
practically based on the same clinical trials. It is not known 
why there are no more recent clinical trials with larger 
series, but still, in practice, domperidone continues to be 
prescribed, probably based on the individual experience of 
each professional. Recent evidence shows that domperi-
done may cause elongation of the ST segment on the elec-
trocardiogram.12-15 A meta-analysis that evaluated the 
effect of metoclopramide in the treatment of reflux con-
cluded there was no evidence of its efficacy or lack of effi-
cacy.16 However, one should remember the extrapyramidal 
side effects that may be caused by metoclopramide and 
bromopride, and less frequently, by domperidone.3 
Regarding the conducts for infants with GERD, it was 
observed that, in many cases, the interviewed pediatri-
cians’ answers disagreed with the recommendations of 
NASPGHAN/ESPGHAN of 2009.3 This disagreement may be 
due to the lack of knowledge of this new guideline on GERD 
or the difficulty not to medicate infants who have symp-
toms that effectively generate great concern for the family 
and the doctor himself.
A study carried out in 11 European countries, involving 
567 pediatricians, showed that only 1.8% of them fully fol-
lowed the recommendations of NASPGHAN/ESPGHAN of 
2009.17 It also emphasized that 39% of the assessed European 
pediatricians prescribed proton-pump inhibitors for infants 
with unexplained crying and 36% for infants with regurgitation 
Table 3 Practice of pediatricians for a clinical scenario compatible with regurgitation in infants (“physiological reflux”) and 
another clinical scenario compatible with gastroesophageal reflux disease in the first semester of life according to the time of 
graduation from medical school.
Year of graduation in Medicine
Before 2000
(n=51)
2000 to 2005
(n=54)
After 2005
(n=35)
p
Clinical scenario 1 (“physiological reflux”)
Do you request any diagnostic test? No 46 (90.2%) 49 (90.7%) 29 (82.9%) 0.469
Do you prescribe any medication? No 42 (82.3%) 43 (79.6%) 29 (82.6%) 0.908
Do you recommend change in formula? Yes 15 (29.4%) 15 (27.8%) 12 (34.3%) 0.801
Do you recommend a position to sleep? Yes 46 (90.2%) 52 (96.2%) 34 (97.1%) 0.284
Clinical scenario 2 (GERD)
Do you request any diagnostic test? Yes 25 (49.0%) 32 (59.3%) 27 (77.1%) 0.097
Do you prescribe any medication? Yes 43 (84.3%) 49 (90.7%) 30 (85.7%) 0.590
Do you recommend change in diet? Yes 42 (82.4%) 38 (70.4%) 25 (71.4%) 0.313
Do you recommend a position to sleep? Yes 48 (94.1%) 49 (90.7%) 33 (94.3%) 0.742
GERD, gastroesophageal reflux disease.
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and vomiting not associated with complications. Thus, the use 
of proton-pump inhibitors with no precise indication is much 
higher among European pediatricians17 than among Brazilian 
ones, as shown in Table 1. 
It should be noted that most respondents would not rec-
ommend the supine position for an infant with physiological 
reflux or gastroesophageal reflux disease, which is recom-
mended due to lower risk of sudden death.3 It is known that 
the supine position is not the one that provides greater 
reduction of reflux episodes, based on pH monitoring and 
impedance-pH monitoring; however, it is considered that 
the benefits of preventing sudden death are higher than 
those provided by the likely reduction in the manifestations 
of gastroesophageal reflux disease and gastroesophageal 
reflux.3,6 The American Academy of Pediatrics notes that 
the decrease in sudden infant death syndrome has been 
observed since 1992, when it was recommended that 
infants should not sleep in the prone position.18 It is note-
worthy that 85% of 161 parents (aged 17 to 39 years) of 
infants, who were interviewed in a hospital in southwestern 
United States, according to an article published in 2012,19 
believed that the supine position was the safest, and 60% 
of them chose to use it. Those who did not choose the 
supine position mentioned the child’s preference or fear of 
choking or smothering.20 In Brazil, a case-control study20 
compared a group consisting of 33 infants, victims of sud-
den death syndrome, with 192 living infants and 192 infants 
deceased from other causes. It can be verified that in this 
sample of the Brazilian population, the supine position was 
not adopted, as currently recommended worldwide,18 and 
in Brazil, by Pastoral da Criança and the Brazilian Society 
of Pediatrics.20
Regarding the prescription of changing the type of bottle 
for infants with probable clinical picture of “physiological 
reflux disease” or GERD, it was observed that, respectively, 
30% and 75% of respondents recommended changes in the 
diet, generally recommending thickened formula or the 
addition of a thickener to the bottle. This conduct is in 
agreement with the NASPGHAN/ESPGHAN 2009 guideline.3 
However, it is worth mentioning that in two clinical scenar-
ios the possibility of diagnosis of reflux secondary to cow’s 
milk allergy was not considered, although the alternatives 
include formulas with extensively hydrolyzed proteins and 
amino acid-based formula, as suggested in the NASPGHAN/
ESPGHAN guideline.3 However, when the respondents were 
directly questioned about the possibility of gastroesopha-
geal reflux disease being secondary to cow’s milk allergy, 
most of them answered yes. When the 140 respondents 
were asked what formula was their first choice for an infant 
with suspected reflux secondary to cow’s milk allergy at 5 
months old, the following answers were obtained: 70 
(50.0%) recommended formula with extensively hydrolyzed 
protein, 44 (31.4%) formula with soy protein, 16 (11.5%) 
formula with partially hydrolyzed protein, 7 (10.0%) amino 
acid-based formula and 3 (2.1%) soy-based formula. 
Currently, it is considered that infants with cow’s milk 
allergy should receive formula with extensively hydrolyzed 
protein or amino acid-based formula as a substitute diet in 
the first semester of life.3,21 These data show an increase in 
the number of correct answers by pediatricians regarding 
substitutes for cow’s milk for infants with cow’s milk aller-
gy when compared to that observed in a previous study,22 
which showed that approximately 80% would prescribe soy 
formula and 40% soy extract, with the last option being 
inadequate to meet the nutritional requirements of infants. 
In conclusion, the results showed that the pediatricians 
have a good level of knowledge, compatible with the pos-
sibility of differentiating physiological reflux from GERD. 
The possibility of reflux secondary to allergy to cow’s milk 
does not seem to be consistent with the guideline of 
NASPGHAN/ESPGHAN. It was also verified that many pedia-
tricians would recommend positions different from the 
supine position (associated with increased risk of sudden 
death) and prescribe prokinetics, not in accordance with 
the guidelines published in 2009 by NASPGHAN/ESPGHAN.3
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